On this page

Kinrix

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Kinrix
Proper name
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
Licence type
351(a)
BLA number
125260
Applicant
GlaxoSmithKline Biologicals
Center
CBER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
0.5ML Injection Intramuscular Single-Dose Vial Rx June 24, 2008

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity